US 9849133
Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
granted A61KA61K31/417A61K31/472
Quick answer
US patent 9849133 (Pharmaceutical formulations of xanthine or xanthine derivatives, and their use) held by Eton Pharmaceuticals, Inc. expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eton Pharmaceuticals, Inc.
- Grant date
- Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/417, A61K31/472, A61K31/522, A61K31/5575